Liu, JingLivingston, Man J.Dong, GuieTang, ChengyuanSu, YunchaoWu, GuangyuYin, Xiao-MingDong, Zheng2018-08-132018-08-132018-02-23Liu, J., Livingston, M. J., Dong, G., Tang, C., Su, Y., Wu, G., … Dong, Z. (2018). Histone deacetylase inhibitors protect against cisplatin-induced acute kidney injury by activating autophagy in proximal tubular cells. Cell Death & Disease, 9(3). https://doi.org/10.1038/s41419-018-0374-72041-4889https://hdl.handle.net/1805/17123Histone deacetylase inhibitors (HDACi) have therapeutic effects in models of various renal diseases including acute kidney injury (AKI); however, the underlying mechanism remains unclear. Here we demonstrate that two widely tested HDACi (suberoylanilide hydroxamic acid (SAHA) and trichostatin A (TSA)) protect the kidneys in cisplatin-induced AKI by enhancing autophagy. In cultured renal proximal tubular cells, SAHA and TSA enhanced autophagy during cisplatin treatment. We further verified the protective effect of TSA against cisplatin-induced apoptosis in these cells. Notably, inhibition of autophagy by chloroquine or by autophagy gene 7 (Atg7) ablation diminished the protective effect of TSA. In mice, TSA increased autophagy in renal proximal tubules and protected against cisplatin-induced AKI. The in vivo effect of TSA was also abolished by chloroquine and by Atg7 knockout specifically from renal proximal tubules. Mechanistically, TSA stimulated AMPK and inactivated mTOR during cisplatin treatment of proximal tubule cells and kidneys in mice. Together, these results suggest that HDACi may protect kidneys by activating autophagy in proximal tubular cells.en-USAttribution-NonCommercial-NoDerivs 3.0 United Stateskidney injuryrenal diseaseautophagyArticle